Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Docmode Health Technologies Ltd (DHTL) Share Price & Fundamentals

Company Overview

Founded Year

2017

Listed Year

2024

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Mr. Paresh Jaysih Sampat

Website

https://docmode.org

Company Facts

What we do

Docmode Health Technologies Ltd is an innovative healthcare technology firm providing integrated medical education, clinical practice tools, and research platforms to healthcare professionals globally.

Founded in

2,017

Market share

Emerging leader in digital healthcare education and clinical support platforms with growing adoption in hospitals and standalone providers.

Problem solved

Bridges knowledge gaps in medical education and clinical practice through digital learning and performance assessment solutions to improve healthcare outcomes.

Top clients or who we serve

Healthcare professionals including doctors, surgeons, allied health workers, medical institutions, and pharma companies; B2B and B2C model.

Key management

Mr. Paresh Jaysih Sampat (Managing Director, experienced healthcare leader)

Our journey and innovations

Founded in 2017, pioneered platforms like iNutrimon for clinical nutrition, Gapsule for knowledge sharing, and expanded into CRO services by 2025.

Where we operate

India with growing international partnerships and export of certificate programs globally.

Top products or what we offer

Flagship products include iNutrimon (nutrition management), AIDE (AI clinical decision support), Gapsule (knowledge platform), and SURE (research intelligence).

Top brands

iNutrimon - clinical nutrition management app, widely adopted; AIDE - AI-based clinical decision support; SURE - market research platform; Gapsule - B2B knowledge exchange.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily recurring from subscriptions and platform services with some cyclical education event revenue.

Our industry position

Positioned as an innovative niche player in healthcare technology bridging education and clinical practice.

Financial highlights

FY 2024-25 revenue: ₹42.7 crore; incurred net loss of ₹2.03 crore; investing in growth and platform development.

Geographical revenue split

Predominantly India with emerging international revenue streams.

Order book

-

Whats driving growth

Digital adoption in healthcare education, regulatory emphasis on continuous learning, and expansion of clinical IT tools.

Our future plans

Scaling CRO services, expanding global certificate programs, enhancing AI capabilities, and broadening hospital partnerships.

Our green promise

-

Our people and values

Committed to innovation, professional development, and inclusive healthcare solutions.

Key challenges ahead

Liquidity constraints, defaults on some debt obligations, and compliance delays requiring strategic corrections.

Interesting facts

First Indian healthcare tech firm integrating AI decision support with clinical nutrition and medical education platforms.

Risks and strategy

Financial restructuring underway to manage defaults; focus on operational efficiency and compliance reform.

Market Footprint

Top Clients

Top Clients

Healthcare professionals including doctors, surgeons, allied health workers, medical institutions, and pharma companies; B2B and B2C model.

Top Products

Top Products

Flagship products include iNutrimon (nutrition management), AIDE (AI clinical decision support), Gapsule (knowledge platform), and SURE (research intelligence).

Price Movement & Share Holding

Today's High/Low

21.922.05

52 Week High/Low

21124.6
Past Returns

1 week

-1.12%

1 month

-14.04%

3 month

-41.2%

1 year

-81.2%

3 year

-87.8%

5 year

-87.8%

Share Holding

Promoters

29.5%

FII

0%

DII

0%

Retail

69.84%

Others

0.66%

Company Overview

Founded Year

2017

Listed Year

2024

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Mr. Paresh Jaysih Sampat (Managing Director

Website

https://docmode.org

Price Movement & Share Holding

Today's High/Low

21.922.05

52 Week High/Low

21124.6

Past Returns

1 week

-1.12%

1 month

-14.04%

3 month

-41.2%

1 year

-81.2%

3 year

-87.8%

5 year

-87.8%

Share Holding

Promoters

29.5%

FII

0%

DII

0%

Retail

69.84%

Others

0.66%

Company Facts

What we do

Docmode Health Technologies Ltd is an innovative healthcare technology firm providing integrated medical education, clinical practice tools, and research platforms to healthcare professionals globally.

Founded in

2017

Market share

Emerging leader in digital healthcare education and clinical support platforms with growing adoption in hospitals and standalone providers.

Problem solved

Bridges knowledge gaps in medical education and clinical practice through digital learning and performance assessment solutions to improve healthcare outcomes.

Top clients or who we serve

Healthcare professionals including doctors, surgeons, allied health workers, medical institutions, and pharma companies; B2B and B2C model.

Key management

Mr. Paresh Jaysih Sampat (Managing Director, experienced healthcare leader)

Our journey and innovations

Founded in 2017, pioneered platforms like iNutrimon for clinical nutrition, Gapsule for knowledge sharing, and expanded into CRO services by 2025.

Where we operate

India with growing international partnerships and export of certificate programs globally.

Top products or what we offer

Flagship products include iNutrimon (nutrition management), AIDE (AI clinical decision support), Gapsule (knowledge platform), and SURE (research intelligence).

Top brands

iNutrimon - clinical nutrition management app, widely adopted; AIDE - AI-based clinical decision support; SURE - market research platform; Gapsule - B2B knowledge exchange.

Recurring vs cyclical contribution

Revenue primarily recurring from subscriptions and platform services with some cyclical education event revenue.

Our industry position

Positioned as an innovative niche player in healthcare technology bridging education and clinical practice.

Financial highlights

FY 2024-25 revenue: ₹42.7 crore; incurred net loss of ₹2.03 crore; investing in growth and platform development.

Geographical revenue split

Predominantly India with emerging international revenue streams.

Whats driving growth

Digital adoption in healthcare education, regulatory emphasis on continuous learning, and expansion of clinical IT tools.

Our future plans

Scaling CRO services, expanding global certificate programs, enhancing AI capabilities, and broadening hospital partnerships.

Our people and values

Committed to innovation, professional development, and inclusive healthcare solutions.

Key challenges ahead

Liquidity constraints, defaults on some debt obligations, and compliance delays requiring strategic corrections.

Interesting facts

First Indian healthcare tech firm integrating AI decision support with clinical nutrition and medical education platforms.

Risks and strategy

Financial restructuring underway to manage defaults; focus on operational efficiency and compliance reform.

Market Footprint

Top Clients

Top Clients

Healthcare professionals including doctors, surgeons, allied health workers, medical institutions, and pharma companies; B2B and B2C model.

Top Products

Top Products

Flagship products include iNutrimon (nutrition management), AIDE (AI clinical decision support), Gapsule (knowledge platform), and SURE (research intelligence).

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions